GlassScriptPhysician profile
Armeen Mahvash
NPI 1124031422
$121,684.14
in general payments reported to CMS, 2019-2025
11 companies · $8,903 in 2025
The $8,903 reported for 2025 was more than what 89% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $22K · 2021: $27K · 2022: $18K · 2023: $11K · 2024: $7,774 · 2025: $8,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,250 · Food and Beverage: $3,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,435.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,250.00 |
| Food and Beverage | $3,897.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $104,361.32 | 2019-2025 | Sir-Spheres Microspheres |
| Biocompatibles Uk LTD | $6,082.60 | 2019 | |
| Abk Biomedical USA, INC. | $4,500.00 | 2023 | |
| Boston Scientific Corporation | $3,598.03 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Obsidio |
| Biocompatibles, INC. | $1,627.39 | 2019 | |
| Eisai INC. | $735.00 | 2025 | |
| Terumo Medical Corporation | $514.65 | 2025 | Azur Cx Detachable, Angio-Seal, Glidesheath Slender |
| Delcath Systems | $139.99 | 2024 | Hepzato Kit |
| Siemens Medical Solutions USA, INC. | $85.26 | 2022 | |
| Medtronic, INC. | $39.90 | 2024 | Concertotm, Abre |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armeen Mahvash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.